Neo-adjuvant
Showing 1 - 25 of 5,169
Recurrent Glioblastoma Trial in Brussels (Neo-adjuvant nivolumab and ipililumab IV + adjuvant nivolumab and ipililumab IV,
Not yet recruiting
- Recurrent Glioblastoma
- Neo-adjuvant nivolumab and ipililumab IV + adjuvant nivolumab and ipililumab IV
- +2 more
-
Brussels, BelgiumUZ Brussel
Oct 23, 2023
Esophageal Cancer, Surgery, Neoadjuvant Treatment Trial in Zhengzhou (Neoadjuvant immunochemo)
Recruiting
- Esophageal Cancer
- +3 more
- Neoadjuvant immunochemotherapy
-
Zhengzhou, Henan, ChinaHenan Cancer Hospital (The Affiliated Cancer Hospital of Zhengzh
Oct 2, 2022
Uveal Melanoma Trial in Grand Rapids (Darovasertib)
Recruiting
- Uveal Melanoma
-
Grand Rapids, MichiganThe Cancer and Hematology Centers
Jun 14, 2023
INnovative and Micro-INvasive TEchniques for Early
Recruiting
- Breast Cancer
- Liquid biopsy and imaging
-
Aviano, Pordenone, ItalyCentro di Riferimento Oncologico
Apr 26, 2023
Melanoma Stage III, In-Transit Metastasis of Cutaneous Melanoma Trial in Leiden (Encorafenib + Binimetinib)
Recruiting
- Melanoma Stage III
- In-Transit Metastasis of Cutaneous Melanoma
- Encorafenib + Binimetinib
-
Leiden, Zuid-Holland, NetherlandsLeiden University Medical Center
Mar 2, 2023
Node-positive Breast Cancer Trial (Targeted axillary lymph node dissection)
Not yet recruiting
- Node-positive Breast Cancer
- Targeted axillary lymph node dissection
- (no location specified)
Jan 6, 2023
Pancreatic Cancer Trial in Sydney, Wollongong, Melbourne (Durvalumab, Oxaliplatin, Irinotecan)
Recruiting
- Pancreatic Cancer
- Durvalumab
- +5 more
-
Sydney, New South Wales, Australia
- +2 more
Oct 19, 2023
Pancreatic Cancer Trial in Shatin (MSLN CART)
Not yet recruiting
- Pancreatic Cancer
- MSLN CART
-
Shatin, N.t., Hong KongEndoscopy Centre, Prince of Wales Hospital
Sep 19, 2023
Lung Cancer Trial in Shanghai (Biopsy (baseline), Biopsy (optional, after treatment), Biopsy (optional, relapse and metastasis))
Not yet recruiting
- Lung Cancer
- Biopsy (baseline)
- +2 more
-
Shanghai, ChinaShanghai Pulmonary Hospital
May 11, 2023
Recurrent Glioblastoma Trial in Houston (Pembrolizumab, Exablate MRgFUS + neoadjuvant pembolizumab)
Not yet recruiting
- Recurrent Glioblastoma
- Pembrolizumab
- Exablate MRgFUS + neoadjuvant pembolizumab
-
Houston, TexasM D Anderson Cancer Center
May 18, 2023
Profiling to Help Define Need for Neo-Adjuvant Chemotherapy in
Recruiting
- Breast Cancer
- GEP
-
Jette, Brussel, BelgiumUniversitair Ziekenhuis Brussel
Dec 16, 2022
Neo-adjuvant Chemotherapy Evluation in Gastric Cancer Patients
Recruiting
- Gastric Cancer
- Chemotherapy Effect
- Detection of levels of circulating EV-derived lncRNA-GC1
-
Beijing, Beijing, ChinaChinese PLA General Hospital Ethics Committee
Dec 12, 2022
Cutaneous Squamous Cell Carcinoma Trial in Amsterdam (Nivolumab, Ipilimumab)
Recruiting
- Cutaneous Squamous Cell Carcinoma
-
Amsterdam, Noord Holland, NetherlandsNKI-AVL
Oct 24, 2022
Targeted Axillary Dissection After Neo-adjuvant Chemotherapy
Recruiting
- Breast Cancer
- TAD (Targeted Axillary Dissection)
-
Jette, Brussel, BelgiumUniversitair Ziekenhuis Brussel
Aug 12, 2022
Resectable Soft Tissue Sarcoma, Extremities, Radiotherapy Wound Complications Trial in Cairo (surgical resection with safety
Active, not recruiting
- Resectable Soft Tissue Sarcoma
- +2 more
- surgical resection with safety margin
-
Cairo, EgyptAin Shams University Hospitals
Jun 30, 2022
Anaplastic Thyroid Cancer Trial in Leiden (dabrafenib/trametinib)
Recruiting
- Anaplastic Thyroid Cancer
-
Leiden, Zuid-Holland, NetherlandsEllen Kapiteijn
Oct 5, 2023
Glioblastoma Multiforme Trial in Montréal (Metformin)
Active, not recruiting
- Glioblastoma Multiforme
-
Montréal, Quebec, CanadaMontreal Neurological Institute - McGill University Health Centr
Aug 31, 2022
Oligodendroglioma, Astrocytoma, Grade II, Glioma, Astrocytic Trial in San Francisco (GBM6-AD and poly-ICLC before and after
Active, not recruiting
- Oligodendroglioma
- +5 more
- GBM6-AD and poly-ICLC before and after surgery
- GBM6-AD and poly-ICLC after surgery only
-
San Francisco, CaliforniaUniversity of California
Sep 20, 2022
Rectal Cancer Trial (Chemoradiation treatment, 18FDG-PET/MRI scan)
Not yet recruiting
- Rectal Cancer
- Chemoradiation treatment
- 18FDG-PET/MRI scan
- (no location specified)
Sep 26, 2023
Ovarian Cancer Stage IV, Peritoneal Cancer, Fallopian Tube Cancer Trial in Amsterdam (Carboplatin, Paclitaxel, Pembrolizumab)
Recruiting
- Ovarian Cancer Stage IV
- +2 more
- Carboplatin
- +2 more
-
Amsterdam, NetherlandsAntoni van Leeuwenhoek
Mar 21, 2022
Treated by Neo-adjuvant Combination of Oxaliplatin, Irinotecan,
Recruiting
- Liver Metastasis Colon Cancer
- Synchronous Neoplasm
- Neo-adjuvant Chemotherapy FOLFOXIRI Regimen
- synchronous resection surgery
-
Ho Chi Minh City, VietnamCho Ray hospital- 201 B Nguyen Chi Thanh, District 5
May 5, 2022
Neo-adjuvant Short Course Chemo-radiotherapy in Locally Advanced Cancer Rectum Trial in Assiut (short course chemo-radiation
Recruiting
- Neo-adjuvant Short Course Chemo-radiotherapy in Locally Advanced Cancer Rectum
- short course chemo-radiation with 5-fluorouracil
-
Assiut, Assuit, EgyptAssiut University
Feb 14, 2022